期刊文献+

以双铂为主方案联合化疗治疗小细胞肺癌39例报告 被引量:3

Report of 39 cases of small cell lung cancer treated mainly by double -platinum combined with chemotherapy
下载PDF
导出
摘要 目的 评价以双铂为主方案治疗小细胞肺癌疗效,耐受性及毒副作用。方法 采用CBP-DDP-VP16方案治疗小细胞肺癌39例CRP200~300mg/m^2,第1天,静点,DDP40~60mg/m^2,第8天,静点,Vp16 100mg/m^2第1天至第5天,静点。21天重复。结果 以双铂方案为主治疗小细胞肺癌39例,总有效率79.6%,CR率12.8%。毒性反应主要为骨髓抑制,发生率69.2%。结论 以双铂方案为主治疗小细胞肺癌疗效好,耐受性好,毒副反应轻。 Objective To evaluate the effect, tolerance and toxicity of double-platinum in the treatment of small cell lung cancer. Methods 39patients were treated with CBP- DDP-Vpl6 regime. That is GBP 200-300mg/m2 d1 iv drip, DDP 40-60mg/m2 d6 iv drip, Vpl6 100mg/m2 d1-5 iv drip , repeated every 21 days. Results The total response rate was 76.9% , complete response rate was 12.8% . The main toxicity was bone marrow suppression, the granulocytopenia rate was 69.2% (27/39) . Conclusions Smal ceil lung cancer treated mainly by the double-platinum regime shows better therapeutic effect, and toxic side-effects are tolerant.
机构地区 吉林省肿瘤医院
出处 《实用肿瘤学杂志》 CAS 2003年第2期112-113,共2页 Practical Oncology Journal
关键词 小细胞肺癌 顺铂 卡铂 CBP-DDP-VR6方案 联合化疗 治疗 疗效 DDP CBP Small cell lung cancer
  • 相关文献

参考文献3

  • 1孙燕 等.临床肿瘤内科手册:第3版[M].北京:人民卫生出版社,1996.45.
  • 2吴双,张伟,文浩,杨家林,陈念永.放疗联合同期卡铂加顺铂化疗治疗Ⅲ期非小细胞肺癌[J].临床肿瘤学杂志,2003,8(1):58-58. 被引量:6
  • 3Ryoichi N, Torn K, Tetsuya M, et al. Combined carboplatin and Cisplatin therapy in petients with advanced non - small cell lung cancer, Am J clin oncol, 1997;20(1):31-35.

二级参考文献1

共引文献36

同被引文献21

  • 1王伸勇,张荣久,张奕华,沈宏.铂类抗肿瘤药物的研究现状[J].药学进展,2004,28(6):253-257. 被引量:9
  • 2李凤琴,谢根法,张大锤,于人江,王惠,崔淑香,张强,周玲,徐大江,王建国.卡铂临床前药效及毒理研究[J].癌症,1990,9(6):441-448. 被引量:7
  • 3[1]Christian MC. The current status of new platinum analogs[J]. Semin Oncol, 1992,19(6) :720 - 733.
  • 4[2]Wolfgang GH, Dominick MA, Walsh KM, et al. Comparative nephrotoxicity of a novel platinum compound, cisplatin, and carboplatin in male Wistar rats [ J ]. Fundam Appl Toxicol, 1994,22(1):73-79.
  • 5[3]卫生部药政管理局新药(西药)临床前研究指导原则汇编[M].北京:中华人民共和国卫生部药政局,1993.200-203.
  • 6[4]Go RS, Adjei B. Review of the comparative pharmacology and clinical activity of cisplatin and carboplatin[J]. J Clin Oncol, 1999,17(1):409-422.
  • 7Wong E, Giandomenico CM.Current status of platinum-based antitumor dogs[J]. Chem Rev, 1999,99(9) :2 451 - 2 466.
  • 8Fregona D, Giovagnini L, Ronconi L, et al. Pt(Ⅱ) ahd Pb( Ⅱ ) derivatives of ter-butylsarosine- dithiocarbonate: synthesis,chemical and biological characterization and in vitro nephrotoxicity [ J ]. J Inorg Biochem, 2003,93 (3) : 181 - 189.
  • 9Reedijk J. Improved understanding in platinum antitumor chemistry[J] .J Chem Soc Chem Commun, 1996, (7) : 801 - 806.
  • 10徐叔云.药理试验方法学[M].北京:人民卫生出版社,1991.223-236.

引证文献3

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部